BioSpace News Archive

Kangpu Biopharmaceuticals announced that it has successfully completed a first-in-human phase I single ascending dose clinical study of KPG-818 conducted in the United States.

Hansa Biopharma will publish its interim report for the first nine months of 2019 at 8:00 a.m. CET on October 31, 2019.

Aridis Pharmaceuticals, Inc. announced that it has appointed Paul Mendelman, MD as interim Chief Medical Officer.

The new partnership will combine the research and development ingenuity of BJ Bioscience with the state-of-art biologics manufacturing set up of CMAB

The polytetrafluoroethylene market size is expected to post a CAGR over 7% during the period 2019-2023, according to the latest market research report by Technavio.

TherapeuticsMD, Inc. announced the presentation of ANNOVERA™ findings at the annual meeting of the American Society for Reproductive Medicine being held in Philadelphia, PA on October 12-16, 2019.

NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing next-generation antisense therapies to address genetic diseases, today announced the addition of Steven Dowdy, Ph.D., to its scientific advisory board (SAB)

cbdMD, Inc. (NYSE American: YCBD), a nationally recognized consumer cannabidiol (CBD) brand, is proud to announce its partnership with Save Mart in Modesto, CA, a retailer which operates 207 traditional and price impact stores under the banners of Save Mart, Lucky, Lucky California, FoodMaxx, S-Mart Foods, and Maxx Value Foods.

Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, announced today that its 2019 Annual Meeting of Stockholders, scheduled for October 10, 2019,

Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that it will release third-quarter 2019 results on Wednesday, October 30th, 2019, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.